Intangia is a verifiable B2B SaaS platform for the life sciences industry, offering AI-driven R&D evidence synthesis and portfolio governance. External verification confirms it is a real UK-based company (founded 2022) with backing from Catalyze Advisors and KDX Ventures, employing approximately 6 people. However, the project submission itself contains significant inaccuracies and exaggerated claims (e.g., stating the audience is 'everyone' and 'most people have used my product' for a niche B2B tool), which severely impacts the credibility of the provided metrics. While the technology and market timing are promising, the score is constrained by the niche nature of the actual product and the poor quality of the submission data.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline